Since we previously found that INCR1 regulates the expression of several immunosuppressive genes [19], we hypothesized that silencing INCR1 would increase PBMCs’ cytotoxic activity against tumor cells in response to IL12 stimulation. This evidence concerns the gene INCR1 and neoplasm.